Article metrics

Download PDFPDF

SAT0171 Abp 501 biosmilar to adalimumab: final safety, immunogenicity, and efficacy results from an open-label extension study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20173900
Jul 20171200
Aug 20171201
Sep 20172005
Oct 20171606
Nov 20172204
Dec 20171403
Jan 20182207
Feb 20182404
Mar 20182406
Apr 20182801
May 20182602
Jun 20181401
Jul 20181401
Aug 20182209
Sep 2018804
Oct 201818010
Nov 201845014
Dec 201824013
Jan 201916014
Feb 20194305
Mar 201922012
Apr 20192206
May 2019605
Jun 20191802
Jul 201921011
Aug 20192805
Sep 2019402
Oct 2019803
Nov 2019802
Dec 2019201
Jan 2020406
Feb 2020202
Mar 2020001
Apr 2020805
May 2020204
Jun 20201208
Jul 20201001
Aug 20201205
Sep 20201103
Oct 20201004
Nov 20201202
Dec 20201002
Feb 2021302
Mar 2021301
Apr 2021304
May 2021304
Jun 2021002
Jul 2021005
Aug 2021002
Sep 2021101
Oct 20212016
Nov 202114014
Dec 2021401
Jan 2022802
Feb 2022907
Mar 2022001
May 20221407
Jun 20221803
Jul 20221600
Aug 20221606
Sep 2022607
Oct 20221004
Nov 20221207
Dec 20221400
Jan 2023802
Feb 2023702
Mar 2023801
Apr 2023102
May 2023203
Jun 2023200
Jul 2023403
Aug 2023001
Oct 2023201
Nov 2023200
Dec 20231200
Jan 20241400
Feb 2024201
Mar 20241004
Total9250318